Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Tandem Diabetes Care missed estimated earnings by 23.81%, reporting an EPS of $0.16 versus an estimate of $0.21.
Revenue was up $41.93 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 6.29% drop in the share price the next day.
Here’s a look at Tandem Diabetes Care’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | -0.08 | -0.16 | 0.12 |
| EPS Actual | 0.09 | 0.06 | -0.08 | 0.22 |
| Revenue Estimate | 171.41M | 143.63M | 121.96M | 141.58M |
| Revenue Actual | 179.63M | 172.14M | 141.04M | 168.06M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
